Loading…
Telix Pharmaceuticals Limited is projected to rise to $11.93 by 2027, a +23% move from its current price of $9.74. TLX is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $9.49 | $9.74 | $10.00 | +0.04% |
| May 30 | $9.39 | $9.75 | $10.12 | +0.08% |
| May 31 | $9.32 | $9.75 | $10.20 | +0.12% |
| Jun 1 | $9.26 | $9.76 | $10.28 | +0.16% |
| Jun 2 | $9.20 | $9.76 | $10.35 | +0.20% |
| Jun 3 | $9.16 | $9.76 | $10.41 | +0.24% |
| Jun 4 | $9.11 | $9.77 | $10.47 | +0.28% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $9.11 | $9.77 | $10.47 | +0.28% |
| Week 2 | $8.88 | $9.79 | $10.80 | +0.56% |
| Week 3 | $8.71 | $9.82 | $11.07 | +0.84% |
| Week 4 | $8.58 | $9.85 | $11.31 | +1.13% |
| Week 5 | $8.46 | $9.88 | $11.53 | +1.41% |
| Week 6 | $8.36 | $9.90 | $11.74 | +1.69% |
| Week 7 | $8.27 | $9.93 | $11.93 | +1.98% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Telix Pharmaceuticals Limited is a commercial-stage biopharmaceutical company that focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals.
Its business operates through three segments: Precision Medicine, Therapeutics, and Manufacturing Solutions. Its lead therapeutic candidate is TLX591, a lutetium-labeled radio antibody-drug conjugate (rADC) that is in Phase 3 clinical trials for advanced prostate cancer.
Telix develops a broad slate of products and imaging solutions, including TLX250, TLX101, TLX66, Illuccix and Gozellix, and it operates in Australia, Belgium, Canada, the United Kingdom, the United States, and internationally. The company was founded in 2015 and is headquartered in North Melbourne, Australia, with a strategic collaboration with University Hospital Essen.
TLX is currently priced at $9.47 and has a market capitalization of $3.21B. It is ranked 1665 in the market.
The price outlook, based on the provided year-by-year forecast, shows an upward trajectory with the average price rising from $9.47 in 2026 to $85.14 in 2050, signaling substantial medium- to long-term upside.
Across the forecast, the average price grows from 2026 through 2050, with the years 2027–2050 showing continued bullish sentiment and clear upside potential, as reflected in the rising average values and the accompanying ROI figures.
A major floor 34.2% below — a decisive break under it would weaken the trend.
Price is testing support right now (2.8% away) — a key level to hold.
The nearest ceiling, 15.6% above — a clean break opens room to run.
A major ceiling 22.7% above — clearing it would confirm fresh momentum.
Key TLX support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of TLX market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $9.87 | Sell | $9.84 | Sell |
| MA 10 | $10.17 | Sell | $10.07 | Sell |
| MA 20 | $10.51 | Sell | $10.24 | Sell |
| MA 50 | $10.04 | Sell | $9.89 | Sell |
| MA 100 | $8.69 | Buy | $9.53 | Buy |
| MA 200 | $9.29 | Buy | $10.15 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 42.07 | Neutral |
| Stoch RSI (14) | 23.43 | Neutral |
| CCI (20) | -128.23 | Sell |
| Williams %R (14) | -80.58 | Info |
| MACD (12,26,9) | -0.18 | Sell |
| ROC (12) | -8.80 | Sell |
| Bollinger %B (20,2) | 0.11 | Neutral |
| Stochastic %K (14) | 19.42 | Buy |
| TRIX (15) | 0.12 | Buy |
| Awesome (5,34) | -0.65 | Sell |
| Ultimate (7,14,28) | 28.21 | Buy |
| Momentum (10) | -0.65 | Sell |
| Aroon Osc (25) | -60.00 | Sell |
| Hull MA (9) | 9.50 | Buy |
| ADX (14) | 17.92 | Neutral |
| ATR (14) | 0.23 | Info |
The technical picture is bullish overall, with a current sentiment labeled as BULLISH and RSI14 at 40.
The stock trades near a support level of $9.47 and faces resistance at $11.26. The 30-day price range spans from $7.90 to $11.35, and the 50-day simple moving average sits at $9.97 while the 200-day simple moving average is at $9.31.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $6.41 | $9.74 | $14.11 | 0% | Neutral | |
| $9.50 | $11.93 | $15.85 | +23% | Bullish | |
| $10.62 | $13.68 | $18.81 | +40% | Bullish | |
| $10.73 | $14.13 | $19.96 | +45% | Bullish | |
| $11.93 | $16.01 | $23.16 | +64% | Bullish | |
| $14.68 | $20.05 | $29.59 | +106% | Bullish | |
| $15.89 | $22.07 | $33.17 | +127% | Bullish | |
| $17.71 | $24.98 | $38.17 | +156% | Bullish | |
| $18.66 | $26.70 | $41.42 | +174% | Bullish | |
| $18.03 | $26.17 | $41.17 | +169% | Bullish | |
| $27.45 | $42.44 | $70.86 | +336% | Bullish | |
| $54.21 | $93.39 | $170.15 | +859% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $6.41 | $9.74 | $11.40 | +0.00% |
| June 2026 | $8.29 | $9.72 | $11.67 | -0.16% |
| July 2026 | $8.54 | $10.10 | $12.29 | +3.88% |
| August 2026 | $8.62 | $10.26 | $12.61 | +1.60% |
| September 2026 | $8.60 | $10.29 | $12.74 | +0.27% |
| October 2026 | $8.91 | $10.72 | $13.37 | +4.12% |
| November 2026 | $9.25 | $11.17 | $14.02 | +4.21% |
| December 2026 | $9.21 | $11.17 | $14.11 | +0.03% |
Click any year to see its month-by-month TLX forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, TLX is projected to trade between $6.41 and $14.11, averaging $9.74 — a potential gain of 0% from today's $9.74. A consolidation phase looks the most probable path here.
Telix Pharmaceuticals Limited's 2027 outlook centres on $11.93, within a $9.50 to $15.85 range. That is up +23% on the projected 2026 average. That marks a +23% change versus current levels. Momentum favours further upside here.
By 2028, TLX could reach as high as $18.81, with a base case around $13.68 and support toward $10.62 — roughly +40% from $9.74. Buyers look set to stay in control over this stretch.
Expect TLX to range from $10.73 to $19.96 through 2029. The $14.13 average target implies a +45% move from current prices. That is up +3% on the projected 2028 average. Momentum favours further upside here.
The TLX price prediction for 2030 points to an average of $16.01 (low $11.93, high $23.16) — a potential gain of +64% on today's $9.74. Buyers look set to stay in control over this stretch.
In 2031, TLX is projected to trade between $14.68 and $29.59, averaging $20.05 — a potential gain of +106% from today's $9.74. That is up +25% on the projected 2030 average. Momentum favours further upside here.
Telix Pharmaceuticals Limited's 2032 outlook centres on $22.07, within a $15.89 to $33.17 range. That is up +10% on the projected 2031 average. That marks a +127% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, TLX could reach as high as $38.17, with a base case around $24.98 and support toward $17.71 — roughly +156% from $9.74. Momentum favours further upside here.
Expect TLX to range from $18.66 to $41.42 through 2034. The $26.70 average target implies a +174% move from current prices. That is up +7% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The TLX price prediction for 2035 points to an average of $26.17 (low $18.03, high $41.17) — a potential gain of +169% on today's $9.74. Momentum favours further upside here.
In 2040, TLX is projected to trade between $27.45 and $70.86, averaging $42.44 — a potential gain of +336% from today's $9.74. That is up +62% on the projected 2035 average. Buyers look set to stay in control over this stretch.
Telix Pharmaceuticals Limited's 2050 outlook centres on $93.39, within a $54.21 to $170.15 range. That is up +120% on the projected 2040 average. That marks a +859% change versus current levels. Momentum favours further upside here.
Investing $1,000 in TLX today (≈ 102.669405 TLX) could be worth
$9,588.62
+$8,588.62 (+859%) by 2050 · US Dollar
Based on the average projected TLX price of $93.39 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in TLXwould be worth at today's price.
$1,000 invested in TLX on May 27, 2025 (≈ 59.382422 TLX) would be worth
$578.38
-$421.62 (-42.2%) today · 0.58× · US Dollar
Based on a TLX entry price of $16.84 vs. today's $9.74.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $10.28 | $947.47 | -5.3% |
| 1 month ago | $10.4 | $936.54 | -6.3% |
| 3 months ago | $7.52 | $1,295.21 | +29.5% |
| 6 months ago | $9.95 | $978.89 | -2.1% |
| 1 year ago | $16.84 | $578.38 | -42.2% |
| All time (1.5y) ago | $15.15 | $642.9 | -35.7% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our TLX forecast.
Our base-case forecast reaches $19.00 around 2031.
Implied market cap at $19.00: $6.44B
The multi-year outlook shows a clear rise in the average price and rising ROI across key years. In 2026 the average price is $9.47 with a 0 ROI, moving to a 2027 average of $11.53 with a 21.7 ROI and a 2028 average of $13.14 with a 38.7 ROI. The 2029 average is $13.38 with a 41.3 ROI, and the 2030 average reaches $15.15 with a 60 ROI.
By 2031 the average is $18.93 with a 99.9 ROI, 2032 at $20.70 with an 118.6 ROI, 2033 at $23.58 with a 149 ROI, 2034 at $24.99 with a 163.9 ROI, and 2035 at $24.07 with a 154.2 ROI. The forecast extends to 2040 with an average of $39.08 and a 312.7 ROI, and to 2050 with an average of $85.14 and a 799.1 ROI. These figures imply a bullish trajectory over the long term, though they are estimates and not a guarantee.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $15.15, with a range from $11.19 to $22.13 and a ROI of 60.
Forecasts show a bullish sentiment from 2027 onward with rising averages (e.g., 2027 avg $11.53 and 2028 avg $13.14) and positive ROI (21.7% in 2027, 38.7% in 2028, 41.3% in 2029, and 60% in 2030), though 2026 is neutral.
Yes. The forecast maximum for 2050 is $157.87, indicating potential to surpass $100 by 2050 (2040 max is $66.24; 2050 max is $157.87).
Current price is $9.47 and market capitalization is $3.21B.
The 30-day range is $7.90 to $11.35.
Telix Pharmaceuticals Limited Community Discussion
0Share your Telix Pharmaceuticals Limited price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.